Google Custom Search

NEWS

 

bullet Biomedal will be present at the following fairs and congressess   

 

Event

Date

City

35th International Congress os the Society for Microbial Ecology and Disease (SOMED)

15-17 May

Valencia - Spain

VitafoodsTM Europe

22-24 May

Geneva - Switzerland

“31st Annual Midwest Section AOAC International Meeting and Exposition Meeting”

4-6 June

St. Louis - EEUU

2º Salón de productos y servicios para Alergias e Intolerancias Alimentarias

14-16 June

Madrid - Spain

Bio2012

18-21 June

Boston - EEUU

I International Symposium on Cell and Gene-Based Therapies

28-29 June

Granada - Spain

BioSpain 2012

19-21 September

Bilbao - Spain

21-25 October
Paris - France
12-14 November
Hamburg - Germany
13-15 November
Messe Frankfurt - Germany

 

bullet Biomedal receives an Award of Excellence from media group Joly and banking group Caixa for outstanding Andalucian SMEs.


In Seville on May 25th, banking corporation Caixa and leading media group Joly delivered prizes for their second annual Awards of Excellence in Andalusian SEMs. After evaluating the 65 applications received, the judges decided to award five SEMs in Andalusia, selecting each for their spirit of entrepreneurship and involvement in regional economic development.

 

Biomedal received the award in the category of Health, Welfare and Biotechnology, marking it as one of the most efficient Spanish companies seeking for basic research conducted in public research centers and abroad.

 

Read more...


bullet A group of Israeli Scientists from the Technion-Israel Institute of Technology (Haifa, Israel) has obteined important results using Biomedal´s "Anti-GSTT1 kit".


A group of Israel Scientists from the Technion-Israel Institute of Technology (Haifa, Israel) has obtained important results using BIOMEDALl´s "Anti-GSTT1 ELISA Kit" in studies involving blood sera from children with congenital hemoglobinapathies that received a bone marrow transplantation.

 

The group has successfully expanded the potential applications of this kit, initially developed for diagnosing and monitoring liver graft rejection caused by a de novo autoimmune hepatitis. They have demostrated that after a bone marrow transplantation, the detection of anti-GSST1 antibodies in patients that are null for the GSTT1 gene may be predictive of granft rejection, thus allowing to control and adjust the immunosuppressive therapy.

 

This results have been published in bone Marrow Transplantation (see article).

 

bullet Biomedal has reached an agreement with Yeastern Biotech co ltd.


Biomedal will distribute in Spain all Yeastern Biotech products. This agreement will allow Biomedal to amplify its molecular biology catalogue and offer its clients innovative products with an outstanding quality.


In the first phase, Biomedal will launch the “UniversALL tissue PCR kit” a rapid and user friendly kit to extract and amplify genomic DNA. This kit can be used for any kind of cells and tissues and is particularly convenient for resistant cells where DNA extraction and amplification if difficult.